한국표준정보망

회원가입 로그인 비회원(주문조회) 장바구니 이용안내

English
메뉴
검색 마이페이지 장바구니0

QUICK

닫기

TOP

해외표준 상세정보

관심표준 등록 : 표준업데이트 시 알림서비스

제공형태 더보기

  • subList_img01

    표준

    판매

    ISO 13022:2012

    Medical products containing viable human cells — Application of risk management and requirements for processing practices
    • 발행일 : 2012-03-21
    • 발행기관 : ISO
    즐겨찾기 장바구니 담기
    닫기

    상품이 장바구니에 담겼습니다.

    장바구니로 이동

    • [영어]PDF 307,700원

    • [영어]PRINT 307,700원

상세정보

분야 ISO/TC 194 : Biological and clinical evaluation of medical devices
적용범위

This International Standard specifies requirements and guidance for processing practices and managing risk

associated with viable cellular components of products regulated as medicinal products, biologics, medical

devices and active implantable medical devices, or combinations thereof. It covers viable human materials of

autologous as well as allogeneic human origin, obtained from living or deceased donors.

For manufacturers of medical products containing viable cells of human origin, this International Standard

specifies procedures to be used in processing and handling, as well as those to be used in identifying the

hazards and hazardous situations associated with such cells, in order to estimate and evaluate the resulting

risks, to control these risks, and to monitor the effectiveness of that control. Furthermore, this International

Standard outlines the decision process for the residual risk acceptability, taking into account the balance of

residual risk and expected medical benefit as compared to available alternatives.

This International Standard provides requirements and guidance on risk management related to the hazards

typical of medical products manufactured utilizing viable human materials, such as:

a) contamination by bacteria, moulds, yeasts or parasites;

b) contamination by viruses;

c) contamination by agents causing Transmissible Spongiform Encephalopathies (TSE);

d) contaminating material responsible for undesired pyrogenic, immunological or toxicological reactions;

e) decomposition of the product and degradation products caused by inadequate handling;

f) hazards related to the tumorigenic potential of the cell types used;

g) complications resulting from unintended physiological and anatomical consequences (this includes

unintended migration of cells, unwanted release of biologically active substances such as hormones and

cytokines, and unintended interactions between cellular and non‑cellular components of the product);

h) failure of traceability;

i) complications resulting from the material eliciting an unintended immunogenic reaction.

For the evaluation of contamination with other unclassified pathogenic entities, similar principles might be applicable.

Hazards related to genetic modification are outside the scope of this International Standard and are

addressed elsewhere.

NOTE 1 A definition of "genetically modified" can be found in ASTM F2312.

NOTE 2 This International Standard does not specify a quality management system for the control of all stages of

production of medical products as described above.

If additional national or regional criteria beyond what is defined in this International Standard exist in the

country where the medical product will be used, they are also applicable.

NOTE 3 Regional requirements can be more stringent than requirements referenced in this International Standard,

especially with regard to donor eligibility criteria.

This International Standard is not applicable to:

— non‑viable materials of human origin;

— viable cells of non‑human origin;

— blood and its components used for transfusion, germ cells, organs and bone marrow used for transplantation,

and other tissues that do not meet the definition of "medical product";

— in vitro diagnostic devices.

NOTE 4 For guidance on the application of this International Standard, see Annex A.
국제분류(ICS)코드 11.100.20 : 의료 장비의 생물학적 평가
페이지수 48
Edition 1

이력정보

No. 표준번호 표준명 발행일 상태
1 ISO 13022:2012상세보기 Medical products containing viable human cells — Application of risk management and requirements for processing practices 2012-03-21 표준

관련상품

  • 관련상품이 존재하지 않습니다.

다른 사람이 함께 구입한 상품

추천 상품

제공형태 닫기

  • PDF :

    직접 파일 다운로드 및 인쇄(마이페이지 확인)

  • 보안PDF :

    직접 파일 다운로드 및 인쇄(마이페이지 확인)* 단, 파일이동 및 복사 불가, 1회 다운로드 및 인쇄가능

  • PRINT :

    인쇄본 우편발송, 2~3일 소요(PDF파일 미제공)

  • BOOK :

    인쇄본 우편발송, 2~3일 소요(PDF파일 미제공)

  • ZIP :

    압축파일형태로 제공 (PDF, HTML, TXT, XLS 등으로 구성), 직접 파일 다운로드(마이페이지 확인)

  • CD/DVD :

    직접 파일 다운로드 및 인쇄(마이페이지 확인)

  • DB :

    별도 정보 제공

  • HARDCOPY :

    해외 배송 상품, 최대 3주 소요

  • 바인더 :

    바인더 우편발송, 2~3일 소요

  • 온라인구독 :

    WEB 접속 후 실시간 열람, 출력(1년간)